PortfoliosLab logo
PortfoliosLab logo
Tools
Performance Analysis
Portfolio Analysis
Factor Model
Portfolios
Lazy PortfoliosUser Portfolios
Discussions
ALPN vs. ELF
Performance
Risk-Adjusted Performance
Dividends
Drawdowns
Volatility
Financials

Key characteristics


ALPNELF

Fundamentals


ALPNELF
Market Cap$4.46B$7.40B
EPS-$0.64$1.85
PEG Ratio0.002.03
Total Revenue (TTM)$37.89M$916.56M
Gross Profit (TTM)$37.59M$650.44M
EBITDA (TTM)-$20.85M$139.42M

Correlation

-0.50.00.51.00.1

The correlation between ALPN and ELF is 0.12, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.

Performance

ALPN vs. ELF - Performance Comparison

The chart below displays the growth of a $10,000 investment in both assets, with all prices adjusted for splits and dividends.


-40.00%-30.00%-20.00%-10.00%0.00%10.00%20.00%30.00%JuneJulyAugustSeptemberOctoberNovember0
-21.98%
ALPN
ELF

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Risk-Adjusted Performance

ALPN vs. ELF - Risk-Adjusted Performance Comparison

This table presents a comparison of risk-adjusted performance metrics for Alpine Immune Sciences, Inc. (ALPN) and e.l.f. Beauty, Inc. (ELF). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


ALPN
Sharpe ratio
The chart of Sharpe ratio for ALPN, currently valued at 7.20, compared to the broader market-4.00-2.000.002.004.007.20
Sortino ratio
The chart of Sortino ratio for ALPN, currently valued at 9.35, compared to the broader market-4.00-2.000.002.004.006.009.35
Omega ratio
The chart of Omega ratio for ALPN, currently valued at 2.79, compared to the broader market0.501.001.502.002.79
Calmar ratio
The chart of Calmar ratio for ALPN, currently valued at 6.48, compared to the broader market0.002.004.006.006.48
Martin ratio
The chart of Martin ratio for ALPN, currently valued at 147.15, compared to the broader market0.0010.0020.0030.00147.15
ELF
Sharpe ratio
The chart of Sharpe ratio for ELF, currently valued at 0.62, compared to the broader market-4.00-2.000.002.004.000.62
Sortino ratio
The chart of Sortino ratio for ELF, currently valued at 1.26, compared to the broader market-4.00-2.000.002.004.006.001.26
Omega ratio
The chart of Omega ratio for ELF, currently valued at 1.16, compared to the broader market0.501.001.502.001.16
Calmar ratio
The chart of Calmar ratio for ELF, currently valued at 0.71, compared to the broader market0.002.004.006.000.71
Martin ratio
The chart of Martin ratio for ELF, currently valued at 1.48, compared to the broader market0.0010.0020.0030.001.48

ALPN vs. ELF - Sharpe Ratio Comparison


Rolling 12-month Sharpe Ratio0.002.004.006.008.00JuneJulyAugustSeptemberOctoberNovember
7.20
0.62
ALPN
ELF

Dividends

ALPN vs. ELF - Dividend Comparison

Neither ALPN nor ELF has paid dividends to shareholders.


Tickers have no history of dividend payments

Drawdowns

ALPN vs. ELF - Drawdown Comparison


-50.00%-40.00%-30.00%-20.00%-10.00%0.00%JuneJulyAugustSeptemberOctoberNovember0
-39.76%
ALPN
ELF

Volatility

ALPN vs. ELF - Volatility Comparison

The current volatility for Alpine Immune Sciences, Inc. (ALPN) is 0.00%, while e.l.f. Beauty, Inc. (ELF) has a volatility of 20.27%. This indicates that ALPN experiences smaller price fluctuations and is considered to be less risky than ELF based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


0.00%5.00%10.00%15.00%20.00%25.00%JuneJulyAugustSeptemberOctoberNovember0
20.27%
ALPN
ELF

Financials

ALPN vs. ELF - Financials Comparison

This section allows you to compare key financial metrics between Alpine Immune Sciences, Inc. and e.l.f. Beauty, Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities



Values in USD except per share items